Literature DB >> 1747219

White coat phenomenon in patients receiving antihypertensive therapy.

M G Myers1, R A Reeves.   

Abstract

The occurrence of the white coat phenomenon in hypertensive patients receiving drug therapy was determined in a consecutive series of 71 patients undergoing ambulatory blood pressure (ABP) recordings because of suspected differences between office and ambulatory values. Overall mean (+/- SEM) office blood pressure (BP) was 166 +/- 2/95 +/- 1 v awake ABP 139 +/- 2/86 +/- 1 mm Hg. The white coat phenomenon [(office BP - ABP) greater than or equal to 20/10 mm Hg] was present in 52 of 71 patients: office BP 170 +/- 3/96 +/- 2 v ABP 135 +/- 2/83 +/- 1 mm Hg. A marked white coat effect [(office BP - ABP) greater than or equal to 40/20 mm Hg] was seen in 22 patients with office BP being 178 +/- 4/98 +/- 3 v ABP 131 +/- 3/79 +/- 2 mm Hg. The frequent occurrence of white coat phenomenon in these patients suggests that office BP readings may not always represent usual ABP in patients receiving chronic antihypertensive therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747219     DOI: 10.1093/ajh/4.10.844

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

Review 1.  Doctors record higher blood pressures than nurses: systematic review and meta-analysis.

Authors:  Christopher E Clark; Isabella A Horvath; Rod S Taylor; John L Campbell
Journal:  Br J Gen Pract       Date:  2014-04       Impact factor: 5.386

2.  White coat hypertension: addressing the 10 most important questions.

Authors:  Louis Kuritzky
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

Review 3.  Hypertension and the J-curve. How low should you go?

Authors:  J Onrot
Journal:  Can Fam Physician       Date:  1993-09       Impact factor: 3.275

4.  Prevalence and predictors of white-coat response in patients with treated hypertension.

Authors:  M B MacDonald; G P Laing; M P Wilson; T W Wilson
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

Review 5.  Managing hypertension with ambulatory blood pressure monitoring.

Authors:  William B White; Vinay Gulati
Journal:  Curr Cardiol Rep       Date:  2015-02       Impact factor: 2.931

6.  Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours.

Authors:  Gianfranco Parati; Stefano Omboni; Paolo Palatini; Damiano Rizzoni; Grzegorz Bilo; Mariaconsuelo Valentini; Enrico Agabiti Rosei; Giuseppe Mancia
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-22

7.  Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.

Authors:  Y Lacourcière; J Lefebvre; P Provencher; L Poirier
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

8.  Blood pressure cutoffs for white-coat and masked effects in a large population undergoing home blood pressure monitoring.

Authors:  Audes D M Feitosa; Marco A Mota-Gomes; Weimar S Barroso; Roberto D Miranda; Eduardo C D Barbosa; Rodrigo P Pedrosa; Paula C Oliveira; Camila L D M Feitosa; Andréa A Brandão; José L Lima-Filho; Andrei C Sposito; Antonio Coca; Wilson Nadruz
Journal:  Hypertens Res       Date:  2019-07-02       Impact factor: 3.872

Review 9.  Ambulatory blood pressure monitoring over 24 h: A Latin American Society of Hypertension position paper-accessibility, clinical use and cost effectiveness of ABPM in Latin America in year 2020.

Authors:  Ramiro A Sánchez; José Boggia; Ernesto Peñaherrera; Weimar Sebba Barroso; Eduardo Barbosa; Raúl Villar; Leonardo Cobos; Rafael Hernández Hernández; Jesús Lopez; José Andrés Octavio; José Z Parra Carrillo; Agustín J Ramírez; Gianfranco Parati
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

10.  A Short History of Automated Office Blood Pressure - 15 Years to SPRINT.

Authors:  Martin G Myers
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.